Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports;

• Date: November 09, 2009
• Source: www.fda.gov

The Food and Drug Administration (FDA) published in the Federal Register of September 29, 2008 (73 FR 56487), a direct final rule amending its regulations to require that the holder of a new drug application (NDA) submit certain information regarding authorized generic drugs in an annual report to a central office in the agency. The comment period closed December 15, 2008. FDA is withdrawing the direct final rule because the agency received significant adverse comment

Click here to download the file